Unibest
← Back to patent-cliff list

CAS 370879-49-5

(E)-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-5-(phenyldiazenyl)pyrimidine-4,6-diamine

Codes: RIOC-010

Application context (from source-drug indications)

Pulmonary arterial hypertensionRiociguatPulmonary hypertensionRiociguatChronic thromboembolic pulmonary hypertensionRiociguatThrombosisRiociguatLeft ventricular dysfunctionRiociguatIdiopathic pulmonary arterial hypertensionRiociguat

Source drugs (routes using this intermediate)

DrugTierExpiry
RiociguatTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

RiociguatOriginator routesteps: 9total yield: 14.9 g

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.